ShareHope Medicine Co., Ltd. (TPEX:8403)
Taiwan
· Delayed Price · Currency is TWD 28.35
-0.20 (-0.70%)
May 13, 2025, 1:30 PM CST
ShareHope Medicine Revenue
In the year 2024, ShareHope Medicine had annual revenue of 4.33B TWD with 11.68% growth. ShareHope Medicine had revenue of 1.11B in the quarter ending December 31, 2024, with 4.21% growth.
Revenue
4.33B
Revenue Growth
+11.68%
P/S Ratio
0.84
Revenue / Employee
37.33M
Employees
118
Market Cap
3.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.33B | 452.45M | 11.68% |
| Dec 31, 2023 | 3.87B | -263.75M | -6.38% |
| Dec 31, 2022 | 4.14B | 287.10M | 7.46% |
| Dec 31, 2021 | 3.85B | -248.85M | -6.07% |
| Dec 31, 2020 | 4.10B | 974.99M | 31.21% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 11.34B |
| Caliway Biopharmaceuticals | 40.47M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 19.12B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.93M |
| Pegavision | 6.69B |
| Lumosa Therapeutics | 43.59M |